- Super User
- Progress
- Read Time: 1 min
- Hits: 0
Our Site was ranked the 3rd place in terms of recruitment in the world in the Vivid-1 (AMAM) study. Russia is in the top 5! We thank the team for their excellent work!
Our Site was ranked the 3rd place in terms of recruitment in the world in the Vivid-1 (AMAM) study. Russia is in the top 5! We thank the team for their excellent work!
Permission was obtained from the Ministry of Health of the Russian Federation to conduct three Phase III clinical trials to assess the efficacy and safety of a new oral medicine for patients with moderate or severe Crohn's disease, sponsored by the pharmaceutical company Selgene, Switzerland.
Congratulations to the AMAM Study team on the successful completion of the audit of the sponsor of the pharmaceutical company Eli Lilly!
Successfully passed the visit of the selection center to participate in three clinical trials for the treatment of ulcerative colitis, sponsored by the pharmaceutical company Pfizer